Oncology
Detecting Lung Cancer Early: Lung Cancer Screening in the Family Medicine Practice
The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will also highlight the mortality benefits of diagnosing lung cancer at an early stage and discuss key strategies for patient engagement in the family medicine practice.
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2024-08-09
Lung cancer is the leading cause for cancer-related deaths in Canada. There is evidence that early detection of lung cancer with low-dose computed tomography (LDCT) can reduce lung cancer mortality. The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will also highlight the mortality benefits of diagnosing lung cancer at an early stage and discuss key strategies for patient engagement in the family medicine practice.
This program has received an unrestricted educational grant or in-kind support from AstraZeneca.
Faculty
Stephanie Snow, MD, FRCPC
Stephen Lam, MD, FRCPC
Jeffrey Habert, MD, CCFP, FCFP
Christine Palmay, HBArtSci, MD, CCFP, FCFP
Deanna Telner, MD, Med, CFPC, FCFP
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Recognize the benefits of lung cancer screening on patient outcomes based on results of pilots and trials in and outside of Canada
- Understand Canadian expert consensus recommendations on lung cancer screening
- Describe the guidance on eligibility and referrals for existing lung cancer screening programs and pilots in Canada
- Outline the impact of smoking cessation on lung cancer mortality
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ Credit(s).
Cert+ Program ID#: 200563